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Open access undNon-invasive diagnosis of small nodules in cirrhosisTo the Editor:
In the recent issue of the Journal of Hepatology, Iavarone and
colleagues [1] report the dynamic vascular enhancement pattern
of mass-forming intrahepatic cholangiocarcinoma (ICC) on helical
CT in patients with cirrhosis. The authors conclude that contrast
enhanced CT-scan may be able to be used as a sole imaging tech-
nique for non-invasive diagnosis of nodules developing in cirrho-
sis irrespective of nodule size, because the radiological hallmark
of early homogenous enhancement in the arterial phase and
wash-out in the delayed phase in hepatocellular carcinoma
(HCC) was not observed in any of the ICCs. The absence of con-
trast wash-out in delayed phases in ICCs has been shown also
in a study using magnetic resonance imaging (MRI) for 25
patients with cirrhosis [2]. These ﬁndings do not mean that a
nodule not having the radiological hallmark of HCC is not HCC.
In a prospective study that evaluated small nodules (1–3 cm) in
cirrhosis, using enhanced helical CT-scan and contrast enhanced
ultrasonography (CEUS) in accordance with the 2001 European
Association for the Study of the Liver (EASL) guidelines, among
72 nodules, 14 were hypovascular on both CT-scan and CEUS,
which were all less than 2 cm in diameter, and 5 of which proved
to be HCC by biopsy [3]. Of 63 well-differentiated HCCs with a
mean size of 1.57 cm, only 8 (13%) had the radiological hallmark
of HCC on multi-detector CT [4]. Thus, the radiological hallmark
of large HCCs is not necessarily that of small HCCs. In the study
by Iavarone and colleagues, tumor size did not signiﬁcantly affect
CT-scan appearance of ICC, which is not in keeping with a previ-
ous study, where for tumors smaller than 3 cm in diameter, there
was no signiﬁcant difference between the enhancement pattern
of ICC and that of HCC [5]. The discrepancy between the studies
might be attributable to the different characteristics of ICCs reg-
istered and/or different techniques for contrast enhanced CT-
scan. It should be noted that smaller nodules have lesser risk of
malignancy, leading to the recommendation of follow-up of a
nodule smaller than 1 cm in the guidelines. Following the publi-
cation of a study showing that early enhancement in the arterial
phase followed by wash-out in the delayed phase on CEUS did
not discriminate between HCC and ICC [6], the American Associ-
ation for Study of Liver Diseases (AASLD) updated the guidelines,
in which one imaging technique (CT-scan or MRI) excluding CEUS
is advocated for diagnosing even small liver nodules. Another
reason for withdrawal of CEUS from the diagnostic algorithm in
the AASLD guidelines is unavailability of speciﬁc contrast agents
producing microbubbles for ultrasonography in the United States,
but which are available in Europe, Canada, and Asia [7]. In the
updated EASL guidelines, two imaging techniques are recom-
mended for diagnosing small liver nodules although one imaging
technique is also acceptable, and the role of CEUS is controversial
in non-invasive diagnosis of HCC in cirrhosis [8]. In the AsianJournal of Hepatology 2
er CC BY-NC-ND license.Paciﬁc Association for the Study of the Liver guidelines, CEUS
on its own is an accepted imaging modality for HCC diagnosis [7].
The vascular enhancement pattern shown by contrast
enhanced CT-scan appears to be dependent on tumor activity
and the amount of interstitial space in the ﬁbrous stroma of an
individual ICC [9], implying varying appearances of ICC. In fact,
in the study by Iavarone and colleagues [1], variable vascular pat-
terns of ICC in early and delayed phases were observed. Other
than HCCs and ICCs, a variety of non-neoplastic, preneoplastic,
and neoplastic lesions develop in the cirrhotic liver, such as focal
fatty inﬁltration, arterioportal shunt, immature abscesses, macro-
regenerative nodules, hepatic tuberculosis, focal nodular hyper-
plasia, dysplastic nodules, hemangiomas, and metastatic nodules
from other sites [9,10]. HCC and ICC with atypical imaging
features are likely difﬁcult to be distinguished from such lesions
by the dynamic vascular enhancement pattern on CT-scan
alone. Using Kupffer cell-speciﬁc and/or hepatocyte-speciﬁc
contrast agents, additional CEUS or MRI may be warranted for
non-invasive diagnosis of small nodules in cirrhosis.
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To the Editor:
We appreciate Dr. Fujita comments on our study on the diag-
nostic accuracy of contrast enhanced CT-scan to evaluate the
dynamic vascular enhancement pattern of intrahepatic cholan-
giocarcinoma (ICC) in cirrhotic patients [1]. One comment is
that lack of the radiological hallmark of hepatocellular carci-
noma (HCC, wash-in followed by wash-out) does not preclude
the diagnosis of an HCC with an atypical vascular behavior
and that the typical hallmark is less often found in small and
well differentiated tumors. We could not agree more on this
remark, which is in agreement, and not in contrast, with our
article. Indeed, we also previously reported that the radiological
contrast imaging hallmark of HCC occurs in less than 25% of
small well differentiated HCCs [2]. To limit the rates of false
negative diagnosis and thus the need for biopsies, we therefore
suggested the sequential application of contrast imaging tech-
niques, i.e., contrast enhanced CT-scan (CT), magnetic resonance
(MRI) or ultrasound (CEUS), accompanied by histological charac-
terization of the nodule whenever radiology fails to provide a
diagnosis [3]. As a matter of fact, this algorithm with CT and
MRI as imaging techniques has been endorsed by the American
Association for the Study of Liver Disease [4] and partially by
the European Association for the Study of the Liver [5]. With
the addition of CEUS, the algorithm has been adopted in Italy
[6] and in Asia [7,8]. Additionally, Dr. Fujita points out that
the similar behavior of ICC smaller or larger than 3 cm is some-
how unexpected. What is important to note is that most of our
ICC were discovered during surveillance of cirrhotic patients,
which means that even those beyond 3 cm (a minority of cases,
less than 40%) were actually only rarely large (>5 cm), which
could explain the possible discrepancy with previous reports
in which tumors >3 cm were most often very large, implying a
higher rate of intratumoral necrosis leading to atypical patterns.
Moreover, we disagree on Dr. Fujita comments on the interpre-
tation of the discrepancies in the diagnostic accuracy of contrast
CT scan between ours and the study by Kim et al. concerning
nodules less than 3 cm in size [9]. We would like to think that
such discrepancies reﬂect a misinterpretation of the study
results, possibly owing to the adoption of different CT-scan
techniques and application of different protocols of image
acquisition, speciﬁcally, the lack of a delayed venous phase anal-
ysis in Kim study, i.e., the absence of an overview of all phases
of CT-scan. Another problem with that study could relate to the
small sample size of the study which included 8 ICCs smaller
than 3 cm only, of which only 2 had central and peripheral
enhancement pattern in the arterial phase, still in the absence
of any detail regarding the corresponding venous pattern. Fur-
ther complicating the interpretation of Kim and colleagues data,
are the 5 nodules with a wash-out in the venous phase lacking
any description of the arterial phase. Thus, we strongly believe
that without an accurate description of the enhancement
pattern of the nodules throughout the three vascular phases of
contrast imaging, as we did in our study, it is rather impossible
to establish a diagnosis of HCC ruling out ICC in cirrhosis [1]. In
other words, our conclusion was that CT-scan poorly suffers
from the risk of misdiagnosis of ICC for HCC, but also that ICC
cannot be diagnosed by imaging and requires a biopsy. There-
fore, we are in keeping with the comment of Dr. Fujita that
HCC and ICC with atypical imaging features are likely difﬁcult
to be distinguished from other non-malignant lesions by the
dynamic vascular enhancement pattern on CT-scan alone, which
means that a biopsy is required. On practical ground, we also
previously commented on the role of CEUS in this setting, which
leads to the possibility of using ultrasonography to the same
end [10], with the well-known limits of CEUS in terms of
staging. In this connection, let us also elaborate on Dr. Fujita
comment regarding the diagnostic role of Kupffer cell-
speciﬁc contrast agent Sonazoid in CEUS, which may be used
for the non-invasive diagnosis of small nodules in cirrhosis.
While it is well recognized that the diagnostic ability of this
contrast medium relies on the lack of Kupffer cells in the mes-
enchymal meshwork of the malignant lesions, at variance with
normal and cirrhotic liver parenchyma and most solid benign
liver nodule, thereby resulting in a ﬁlling defect of the contrast
during the post-vascular phase, yet, this CEUS fails to distin-
guish between the two different malignant tumors ICC and
HCC [11].
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